Lilly sales inch up on demand for animal health, new drugs
July 23, 2015 at 06:37 AM EDT
July 23 (Reuters) - Eli Lilly and Co said its quarterly revenue rose about 1 percent, helped by demand for its new cancer and diabetes treatments and the acquisition of Novartis AG's animal health business.
